Correction to: Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections

No authors listed

Comment

No authors listed. Open Forum Infect Dis. 2023.

. 2023 Aug 22;10(8):ofad446.

doi: 10.1093/ofid/ofad446. eCollection 2023 Aug.

Abstract

[This corrects the article DOI: 10.1093/ofid/ofad335.].

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.

Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections.
Mingora CM, Bullington W, Faasuamalie PE, Levin A, Porter G, Stadnick R, Varley CD, Addrizzo-Harris D, Daley CL, Olivier KN, Winthrop KL, Dorman SE, Flume PA. Mingora CM, et al. Open Forum Infect Dis. 2023 Jul 3;10(7):ofad335. doi: 10.1093/ofid/ofad335. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37476076 Free PMC article.

Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections.
Mingora CM, Bullington W, Faasuamalie PE, Levin A, Porter G, Stadnick R, Varley CD, Addrizzo-Harris D, Daley CL, Olivier KN, Winthrop KL, Dorman SE, Flume PA. Mingora CM, et al. Open Forum Infect Dis. 2023 Jul 3;10(7):ofad335. doi: 10.1093/ofid/ofad335. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37476076 Free PMC article.